Get notified when TDOC files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: TDOC Teladoc Health, Inc. 8-K

Teladoc expands board to 10 directors, appoints former Verisk Analytics COO Mark Anquillare

Filed August 3, 2026 · Period ending August 3, 2026 · ~1 min read

Key Changes

  • medium

    Board expanded from 9 to 10 directors and appointed Mark V. Anquillare, former president and COO of Verisk Analytics, effective August 3, 2026.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • medium

    Anquillare designated as independent director and audit committee financial expert under SEC and NYSE rules; assigned to both audit and compensation committees.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • low

    Anquillare brings 30+ years of financial and executive leadership experience, including serving as Verisk's CFO from 2007 and leading the company through its 2009 IPO.

    Exhibit 99.1 view on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (TRS 10-Q) is open in full — no account needed.

Partner

Trade TDOC commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 4, 2026 · How we verify